331920.KQ WACC - Weighted Average Cost of Capital
The WACC of Celemics Inc (331920.KQ) is 7.6%.
| Range | Selected | |
| Cost of equity | 6.3% - 9.3% | 7.8% |
| Tax rate | 22.1% - 22.3% | 22.2% |
| Cost of debt | 5.0% - 5.0% | 5% |
| WACC | 6.2% - 9.1% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.55 | 0.76 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.3% | 9.3% |
| Tax rate | 22.1% | 22.3% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 5.0% | 5.0% |
| After-tax WACC | 6.2% | 9.1% |
| Selected WACC | 7.6% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| 331920.KQ | Celemics Inc | 0.04 | 2.03 | 1.97 |
| 038290.KQ | Macrogen Inc | 0.47 | 0.89 | 0.65 |
| 043090.KQ | Cube&Company Co Ltd | 2.66 | -0.63 | -0.2 |
| 087010.KQ | Peptron Inc | 0 | -0.19 | -0.19 |
| 141080.KQ | LegoChem Biosciences Inc | 0 | 0.61 | 0.61 |
| 245620.KQ | Eone Diagnomics Genome Center Co Ltd | 1.24 | 0.59 | 0.3 |
| 4572.T | Carna Biosciences Inc | 0.01 | 1.17 | 1.16 |
| 6090.T | Human Metabolome Technologies Inc | 0.05 | 0.35 | 0.33 |
| BPH.AX | BPH Energy Ltd | 0.01 | 0.17 | 0.17 |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.01 | 0.84 | 0.84 |
| Low | High | |
| Unlevered beta | 0.32 | 0.62 |
| Relevered beta | 0.33 | 0.64 |
| Adjusted relevered beta | 0.55 | 0.76 |
331920.KQ's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 331920.KQ:
cost_of_equity (7.80%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.55) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.